✦ LIBER ✦

N-Terminal probrain natriuretic peptide as a biochemical marker in the evaluation of bosentan treatment in systemic-sclerosis-related pulmonary arterial hypertension

✍ Scribed by Theodoros Dimitroulas; Georgios Giannakoulas; Haralambos Karvounis; Georgios Koliakos; Tilemahos Sfetsios; Hara Dimitroula; Loukas Settas

Publisher: Springer
Year: 2008
Tongue: English
Weight: 91 KB
Volume: 27
Category: Article
ISSN: 0770-3198
DOI: 10.1007/s10067-007-0828-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

N-terminal pro-brain natriuretic peptide

N-terminal pro-brain natriuretic peptide in systemic sclerosis related pulmonary arterial hypertension under bosentan treatment

✍ Theodoros Dimitroulas; Georgios Giannakoulas; Haralambos Karvounis; Hara Dimitro 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 110 KB

N-terminal pro–brain natriuretic peptide

N-terminal pro–brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers

✍ Y. Allanore; D. Borderie; C. Meune; L. Cabanes; S. Weber; O. G. Ekindjian; A. Ka 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB 👁 2 views

High N-terminal pro–brain natriuretic pe

High N-terminal pro–brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis

✍ Y. Allanore; D. Borderie; J. Avouac; D. Zerkak; C. Meune; E. Hachulla; L. Moutho 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Abstract ## Objective To evaluate predictors of pulmonary arterial hypertension (PAH) in a prospective cohort of patients with systemic sclerosis (SSc). ## Methods Routine clinical assessments as well as measurements of the diffusing capacity for carbon monoxide/alveolar volume (DLCO/VA) rati